Delivery Order SPE2DB22D2007-SPE2DB25FJ5GR
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Phenobarbital 65 mg/mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,018.74 and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $1,789.75 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This firm fixed-price, competitively awarded contract contains no set-aside designation and is scheduled for completion by July 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a $1,095.09 delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/ml vials, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger federal contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Phenobarbital 65 mg/ml vials, with a ceiling value of $4,516.61 and an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,494.60 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/ml vials, with an ultimate completion date of April 8, 2025. This firm fixed price delivery order, awarded on April 7, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,089.00 for Phenobarbital 65 mg/mL vials by the Defense Department's Medical Supply Chain. This contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price contracting and was awarded competitively with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,562.39 to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order valued at $1,270.51 to AmerisourceBergen Drug Corp for Phenobarbital 65 mg/mL vials, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 9, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,442.24. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of June 10, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division, which procures critical...
- The Defense Logistics Agency awarded a $3,285.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 130 mg/ml vials. The contract represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5GRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Phenobarbital 65 mg/mL vials with a firm fixed price ceiling value of $1,552.57. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/24/25 |